Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
US9566257B2 · kind B2 · utility
12Cited by
24References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 13, 2012 |
| Grant date | Feb 14, 2017 |
| Priority date | — |
| Expiry date | Jun 13, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to use of ornithine in the manufacture of a medicament for use in combination with at least one of phenylacetate and phenylbutyrate for preventing or treating liver decompensation or hepatic encephalopathy. The invention also relates to use of at least one of phenylacetate and phenylbutyrate in the manufacture of a medicament for use in combination with ornithine for preventing or treating liver decompensation or hepatic encephalopathy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.